Kavya Ramkumar
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Microtubule and mitosis dynamics, Cancer Mechanisms and Therapy, Phagocytosis and Immune Regulation, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities(2021)886 cited
- → STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype(2020)200 cited
- → Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors(2009)153 cited
- → Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC(2019)119 cited
- → The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer(2021)114 cited
- → Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer(2021)62 cited